SULPRIX amisulpride 100 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 100 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 100 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; hypromellose; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SULPRIX amisulpride 400 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 400 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; sodium starch glycollate type a; magnesium stearate; lactose monohydrate; titanium dioxide; macrogol 400 - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN TABLET 200 mg Singapore - English - HSA (Health Sciences Authority)

solian tablet 200 mg

sanofi-aventis singapore pte. ltd. - amisulpride - tablet - 200 mg - amisulpride 200 mg

SOLIAN 100 amisulpride 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

solian 100 amisulpride 100 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; hypromellose; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN amisulpride 100mg/mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

solian amisulpride 100mg/ml oral solution bottle

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: methyl hydroxybenzoate; hydrochloric acid; propyl hydroxybenzoate; purified water; potassium sorbate; saccharin sodium; gluconolactone; sodium gluconate; flavour - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Amisulpride Thame 100mg/ml Sugar Free Oral Solution Malta - English - Medicines Authority

amisulpride thame 100mg/ml sugar free oral solution

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - amisulpride - oral solution - amisulpride 100 mg/ml - psycholeptics

SULPRIX amisulpride 50 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 50 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 50 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; lactose monohydrate; hypromellose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

APOTEX-Amisulpride 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apotex-amisulpride 100 mg tablet blister pack

gm pharma international pty ltd - amisulpride, quantity: 100 mg - tablet - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; methylcellulose; microcrystalline cellulose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.